APA (7th ed.) Citation

Fan, J., Yang, Y., Grimstein, M., Zhang, X., Kitabi, E., Earp, J. C., . . . Wang, Y. (2022). Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction. Clinical pharmacology and therapeutics, 111(3), 624. https://doi.org/10.1002/cpt.2445

Chicago Style (17th ed.) Citation

Fan, Jianghong, et al. "Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction." Clinical Pharmacology and Therapeutics 111, no. 3 (2022): 624. https://doi.org/10.1002/cpt.2445.

MLA (9th ed.) Citation

Fan, Jianghong, et al. "Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction." Clinical Pharmacology and Therapeutics, vol. 111, no. 3, 2022, p. 624, https://doi.org/10.1002/cpt.2445.